Navigation Links
UBC gains $5.4 million for microbiome research from CIHR, Genome BC
Date:10/14/2010

The University of British Columbia today welcomed the announcement of $5.4 million in funding from the Canadian Institutes of Health Research (CIHR) and Genome British Columbia for research into how micro-organisms affect human health.

Two projects, led by UBC researchers Brett Finlay and Deborah Money, were part of seven grants totaling $15.5 million announced today in Toronto by federal Health Minister Leona Aglukkaq.

"We are surrounded by microbes and yet we know relatively little about them," says John Hepburn, UBC Vice President Research and International. "The emerging field of microbiomics will contribute new knowledge to improve the health of Canadians and people around the world. We are grateful for this significant investment from the federal government and Genome BC."

Finlay's project will examine the impact intestinal microbes have on the immune system and their potential connection to asthma. It is supported by $2.5 million from CIHR and $625,000 from Genome BC. Finlay is a professor of microbiology at UBC's Michael Smith Laboratories. His team consists of researchers from UBC and the Child & Family Research Institute.

Money's project will use the latest genome sequencing tools to determine what contributes to a healthy balance of microorganisms in the vagina, and how an imbalance may be associated with preterm delivery, genital tract infection and overall reproductive health. It is supported by

$1.7 million from CIHR and $581,000 from Genome BC. Money is a professor of obstetrics and gynaecology at UBC's Faculty of Medicine and executive director of the Women's Health Research Institute (WHRI) at BC Women's Hospital & Health Centre, an agency of the Provincial Health Services Authority. Her team consists of researchers from UBC, WHRI, National Research Council and the Universities of Saskatchewan, Western Ontario, Guelph and Toronto.


'/>"/>

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia
Source:Eurekalert

Page: 1

Related biology news :

1. Investigational ovarian cancer drug shows promise against platinum resistant disease
2. New tool in the fight against tuberculosis
3. Proteins to yield new clues in fight against osteoporosis
4. Garlic oil shows protective effect against heart disease in diabetes
5. Putting on the pounds after weight loss? Hit the gym to maintain health gains
6. Eating broccoli could guard against arthritis
7. Wildflower armors itself against disease
8. Researchers discover novel mechanism protecting plants against freezing
9. New analysis weighs lost trade, costs to control invasive species against economic damages
10. MSU project may lead to new approaches against lung cancer
11. Study shows that hitchhiking bacteria can go against the flow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... LAS VEGAS , Jan. 4, 2017  For the thousands of ... , a global leader in connected health and biometric measurement devices and ... pressure monitors. On display in A&D Medical,s special CES ... monitors represent the ongoing expansion of the company,s WellnessConnected product ... ...
(Date:12/20/2016)... LONDON , Dec. 20, 2016 ... car sharing, rental and leasing is stoking significant ... of radio frequency technology, Bluetooth low energy (BLE), ... emerge as the next wave of wireless technologies ... vehicle access system to advanced access systems opens ...
(Date:12/16/2016)... YORK , Dec. 16, 2016 The global wearable ... USD 12.14 billion by 2021 from USD 5.31 billion in 2016, ... ... is mainly driven by technological advancements in medical devices, launch of ... rising preference for wireless connectivity among healthcare providers, and increasing focus ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... ... of the latest paper by its Science Editor, Dr. Elisabeth Bik, in the ... Medische Microbiologie). Dr. Bik joined uBiome in October 2016 from her previous position ...
(Date:1/18/2017)... 18, 2017 Shareholder rights law firm Johnson ... the board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... with the proposed sale of the Company to Eli ... develops small molecules for the acute treatment of migraines. ... had signed a definitive merger agreement with Eli Lilly. ...
(Date:1/18/2017)... , Jan. 18, 2017  Caris Life Sciences, ... Lustgarten Foundation, the largest private funder of pancreatic ... trial evaluating the impact of immunotherapy in the ... trial enrollment services to identify potential trial candidates ... between treating physicians and study investigators. The Lustgarten ...
(Date:1/18/2017)... , Jan. 18, 2017  Market Research Future published a half-cooked ... is expected to grow at a CAGR of 12% during the ... ... due to the abnormal cell division without any control. These abnormal ... to them. These cancer cells can spread to other parts of ...
Breaking Biology Technology: